セールス 変化する 日付
ALKERMES USD 480.13M 15.88M 2026-09
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Amarin USD 49.22M 451K 2025-12
ANI Pharmaceuticals USD 290.77M 24.77M 2026-09
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 450.82M 375.59M 2026-09
Eisai JPY 235.63B 1.3B 2026-09
Emergent BioSolutions USD 276.6M 6.1M 2023-12
GlaxoSmithKline GBP 8.89B 480M 2026-09
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 524.42M 98.93M 2026-09
Ligand Pharmaceuticals USD 78.75M 4.95M 2026-09
Merck USD 18.1B 1.5B 2026-09
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 1.12B 161M 2026-09
Pacira USD 176.65M 15.75M 2026-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
Veracyte USD 151.75M 1.43M 2026-09
Vertex Pharmaceuticals USD 3.44B 110M 2026-09